Cannim-LogoCannim-LogoCannim-LogoCannim-Logo
  • Home
  • About Us
  • Our Team
  • Operations
  • Investors & Partners
  • Cannabis
    • News and Resources
  • Contact
MEDICAL CANNABIS IN EUROPE: The Markets & Opportunities (May 2019)
July 31, 2019
July 31, 2019
Categories
  • Legislation and access
Tags

The Therapeutic Goods Administration as part of the Australian Government Department of Health has published a number of documents as guidance on accessing medicinal cannabis for specific issues. See https://www.tga.gov.au/access-medicinal-cannabis-products-1 for general information.

Please see https://www.tga.gov.au/medicinal-cannabis-guidance-documents for more information.

  1. Multiple sclerosis – Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis in Australia
  2. Palliative care – Guidance for the use of medicinal cannabis in the treatment of palliative care patients in Australia
  3. Epilepsy – Guidance for the use of medicinal cannabis in the treatment of epilepsy in paediatric and young adult patients in Australia
  4. Nausea and vomiting – Guidance for the use of medicinal cannabis for the prevention or management of nausea and vomiting in Australia
  5. Pain – Guidance for the use of medicinal cannabis in the treatment of chronic non-cancer pain in Australia
Share
0
matterdesign
matterdesign

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Restoring Health



Interested in Cannim?

  • About Us
  • Investors
  • Contact
© 2019 Cannim. All Rights Reserved.